BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for Sept. 9, 2020

Sep. 9, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Ascletis, Asia Green, Atomwise, Berg, Biontech, Biopharma-Middle East and Africa, Caladrius, Chromadex, Cleave, Datavant, Eveliqure, Galmed, GC Pharma, Gigagen, Global Blood Therapeutics Inc., Ibio, Inveniai, Jazz, Johnson & Johnson, Lexicon, Lineage, Merck, Modulus, Monopar, Nkmax, Noden, Ocugen, Otsuka, Pathway, PDL, Pfizer, PNW, Presage, Prism, Redx, SXT, Takeda, Tersera, Tscan, Valneva, Versatope.
Read More

In the clinic for Sept. 9, 2020

Sep. 9, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AGTC, Alligator, Ampio, Amryt, Astrazeneca, Aztherapies, Brain Neurotherapy, Cellectar, Clearside, Enterome, Flexion, Intensity, Intra-Cellular, Leukemia & Lymphoma Society, Lipac, Merck, Myokardia, Neurosense, Octapharma, Regenxbio, Roche, Scholar Rock, Sinovac, Trillium, Viking.
Read More
Coronavirus and DNA

Novacyt launches respiratory virus test panel that differentiates COVID-19 from common winter diseases

Sep. 8, 2020
By Bernard Banga
PARIS – Novacyt SA has obtained CE marking approval for its polymerase chain reaction (PCR) respiratory virus test panel, Winterplex.
Read More
Coronavirus vaccine illustration

Spybiotech, Serum Institute of India partner on VLP-based COVID-19 vaccine

Sep. 8, 2020
By Cormac Sheridan
DUBLIN – Spybiotech Ltd. has secured a first vaccine deal for its proprietary Spytag/Spycatcher protein conjugation technology. The Serum Institute of India Pvt. Co. Ltd. (SIIPL) is employing the technology in a COVID-19 virus-like-particle (VLP)-based vaccine, which recently entered a phase I/II trial in Australia. An initial data readout is expected in October or November.
Read More

Other news to note for Sept. 8, 2020

Sep. 8, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acutus, Alkahest, Arches Research, Assure Holdings, Avacta, Cambus Medical, Co-Diagnostics, Confirm Biosciences, Cytosorbents, Diagnos, Diasorin, Fluidigm, Freudenberg Medical, Grifols, Inovio, Irhythm, Labcorp, Memed, Merit Medical, Neuronostics, Polarity TE, Qiagen, Roche Canada, Seegene, Thermo Fisher Scientific.
Read More

Other news to note for Sept. 8, 2020

Sep. 8, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alkahest, Anges, Anheart, Aptorum, Astrazeneca, Auris, Aveo, Avidity, Biodesix, Biomica, Biontech, Briacell, Brickell, Canbridge, Catalent, Cheplapharm, CN, Cymerus, Daiichi Sankyo, Destiny, Exelixis, Exmceuticals, Glaxosmithkline, Grifols, Humanigen, Icanomab, Innovation, Inovio, Intravacc, Johnson & Johnson, Kite, Lineage Cell, Mab, Moderna, Mylan, NBE, Novavax, Pharmacyte, Pharmamar, Phoremost, Protalix, Recce, Redhill, Regenerx, Sanofi, Silence, Sporegen, Takeda, Vaxart, Vaxil, Vyne, Xtalpi, Zyversa.
Read More

In the clinic for Sept. 8, 2020

Sep. 8, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Albireo, Allena, Astrazeneca, Athenex, Bayer, Bellus, Biomarin, BMS, Calliditas, Celularity, Clene, Compugen, Corbus, Cyclo, Goldfinch, HRA Pharma, Insmed, Kamada, Merck, Novartis, Radius, Sanofi, Savara, Silence, Spero, Strongbridge, Synairgen, Transgene, Translate Bio, Valneva, Verona.
Read More

Regulatory front for Sept. 8, 2020

Sep. 8, 2020
The latest global regulatory news, changes and updates affecting biopharma, including: Abbvie, Allergan, Astrazeneca, Calvin Scott, Gedeon Richter, HRA Pharma, Nestle.
Read More

Regulatory actions for Sept. 4, 2020

Sep. 4, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Roche.
Read More

Other news to note for Sept. 4, 2020

Sep. 4, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 54gene, Ascyrus Medical, Cryolife, Ehave, Feinstein Institute, Illumina, Infosys, Kaleidoscope Innovation, Novacyt, Ocular Therapeutix, Organovo, Orthopaedic Innovation Centre, Precipio, T2 Biosystems.
Read More
Previous 1 2 … 377 378 379 380 381 382 383 384 385 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 30, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 30, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing